| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |